The rebound phenomenon after aspirin cessation: the biochemical evidence.
Department of Cardiology, Concord Repatriation General Hospital, Australia. Electronic address: richardalcock@virginmedia.com.
Richard F
RF
Alcock
ANZAC Research Institute, University of Sydney, Australia.
Caroline J
CJ
Reddel
ANZAC Research Institute, University of Sydney, Australia.
Gabrielle J
GJ
Pennings
Department of Cardiology, Concord Repatriation General Hospital, Australia.
Graham S
GS
Hillis
Department of Haematology, Concord Repatriation General Hospital, Australia.
Jennifer L
JL
Curnow
Department of Cardiology, Concord Repatriation General Hospital, Australia.
David B
DB
Brieger
D000328:Adult; D001241:Aspirin / Q000009:adverse effects*; D001669:Biochemical Phenomena; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011446:Prospective Studies; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
Aspirin; Aspirin cessation; Aspirin withdrawal; Rebound effect